Search results (5)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research
27 January 2025
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
University of Oxford unveils new vaccine development partnership
15 November 2024
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian Biotech Innovator, Univercells.
Funding to create world's first ovarian cancer prevention vaccine
4 October 2024
Researchers from Oxford have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.
CRUK funding success to take LynchVax from an OCION Pump Prime award towards a clinical trial
16 September 2024
Fewer than 12 months ago the ‘Oxford Cancer Immuno-Oncology Network’ (OCION) awarded £20,000 Pump Prime funding to a team led by Associate Professor David Church, who has now grown this pot over 27-times in funding from CRUK!
Oxford receives funding to develop a cancer prevention vaccine for Lynch syndrome
10 September 2024
Cancer Research UK funds University of Oxford scientists to develop ‘LynchVax’, the UK’s first vaccine aiming to prevent cancer in people with Lynch syndrome who have a much higher risk of developing several types of cancer.